• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Jenkins David A

    10/17/22 5:24:37 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials
    Get the next $GBS alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    JENKINS DAVID A

    (Last) (First) (Middle)
    C/O GBS INC.
    142 WEST 57TH STREET, 11TH FLOOR

    (Street)
    NEW YORK NY 10019

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    10/04/2022
    3. Issuer Name and Ticker or Trading Symbol
    GBS Inc. [ GBS ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ David A. Jenkins 10/14/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GBS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GBS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sakiris Spiro Kevin (Amendment)

    4/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/10/23 6:09:05 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    Towers Christopher bought 9,090 shares, increasing direct ownership by 1,151% to 9,880 units (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:45:33 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    Sakiris Spiro Kevin bought 112,727 shares (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:43:55 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

    The transaction further solidifies GBS' leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reachGBS' global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) --  GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced it has acquired Intelligent Fingerprinting Limited (IFP), thus expanding the GBS platform of rapid, non-invasive diagnostic testing technologies. In addition, GBS announced it has begun the process of changing its corporate name. I

    10/4/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights

    - Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the time-course of glucose in oral fluids - - Company to host conference call & webcast today at 4:30 p.m. ET - NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time monitoring and diagnostic testing for patients and their primary health practitioners at point of care, today announced its preliminary financial results for the fourth financi

    8/31/22 4:05:00 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31

    NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2022, shortly after the NASDAQ market close on Wednesday, August 31. Management will then host a conference call and webcast at 4:30 p.m. ET. Title:GBS Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call & WebcastDate:Wednesday, August 31, 2022Time:4:30 p.m. ETConference Call Details:Toll-Free: 877-407-3982International: 201-493-6780Conference ID: 1

    8/29/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    SEC Filings

    View All

    SEC Form 8-K filed by GBS Inc.

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/9/24 5:05:16 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by GBS Inc.

    10-Q - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/9/24 8:31:01 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)

    2/7/24 5:05:25 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Towers Christopher bought 9,090 shares, increasing direct ownership by 1,151% to 9,880 units (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:45:33 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    Sakiris Spiro Kevin bought 112,727 shares (SEC Form 4)

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    10/6/23 6:43:55 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Financials

    Live finance-specific insights

    View All

    GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

    The transaction further solidifies GBS' leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reachGBS' global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) --  GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced it has acquired Intelligent Fingerprinting Limited (IFP), thus expanding the GBS platform of rapid, non-invasive diagnostic testing technologies. In addition, GBS announced it has begun the process of changing its corporate name. I

    10/4/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights

    - Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the time-course of glucose in oral fluids - - Company to host conference call & webcast today at 4:30 p.m. ET - NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time monitoring and diagnostic testing for patients and their primary health practitioners at point of care, today announced its preliminary financial results for the fourth financi

    8/31/22 4:05:00 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31

    NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2022, shortly after the NASDAQ market close on Wednesday, August 31. Management will then host a conference call and webcast at 4:30 p.m. ET. Title:GBS Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call & WebcastDate:Wednesday, August 31, 2022Time:4:30 p.m. ETConference Call Details:Toll-Free: 877-407-3982International: 201-493-6780Conference ID: 1

    8/29/22 9:05:00 AM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    $GBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    2/14/24 6:04:24 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    2/13/24 8:08:30 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by GBS Inc. (Amendment)

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    2/5/24 4:18:51 PM ET
    $GBS
    Industrial Machinery/Components
    Industrials